Travis C. Mickle - President & CEO, Director at Zevra Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President & CEO, Director
Stock Symbol
ZVRA on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Travis C. Mickle since 12/3/2024

Holdings reported by Travis C. Mickle for Zevra Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 96.2K $477K $4.96 May 25, 2022 By Mickle Holdings LLC
Common Stock 39.5K $196K $4.96 May 25, 2022 Direct
Common Stock 15.2K $75.6K $4.96 May 25, 2022 By Christal M.M. Mickle 2015 Gift Trust dtd 7/21/15, as trustee
Common Stock 11K $54.7K $4.96 May 25, 2022 By Mickle Investments LLC
Common Stock 9.82K $48.7K $4.96 May 25, 2022 By Travis C. Mickle 2015 Dynasty Trust dtd 7/21/15, Christal M.M. Mickle as trustee
Stock Option (right to buy) 267K Feb 1, 2022 Direct Common Stock

Transactions reported by Travis C. Mickle for Zevra Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.